Batch Release Documents in Pharma: Complete Checklist & Process
2026-05-03
Every document in a pharma batch release dossier — BMR/BPR, CoAs, in-process records, deviation and OOS closures, label reconciliation — plus the QA review process and authorised-person release decision.
In pharmaceutical manufacturing, no batch reaches the market without a formal batch release. It is the final quality gate — a systematic review of every document generated during manufacturing, testing, and packaging, ending in a signed release decision by an authorised person.
This guide lists every document that makes up a batch release dossier, walks the review process those documents feed, and shows how to run the whole thing as an audit-ready workflow. Get it wrong and you face regulatory action, recalls, or worse. Get it right — consistently and traceably — and release becomes a 30-second retrieval instead of a 30-minute file hunt.
Batch release documents — the complete checklist
When QA and the authorised person review a batch for release, they are confirming that a specific set of documents exists, is complete, and tells a consistent story. This is the batch release document pack:
Manufacturing records
- Batch Manufacturing Record (BMR) / Batch Production Record (BPR) — executed, signed, with no blanks
- Master Formula Record (MFR) reference, to confirm the batch followed the approved formula
- In-process control (IPC) records — every in-process check with its result
- Critical process parameter (CPP) logs — temperature, pressure, time, RPM, etc.
- Yield reconciliation — theoretical vs actual, with explanation of any variance
- Line clearance records — confirming no mix-up from the previous product/batch
- Equipment usage logs and current calibration status of equipment used
Testing and analytical records
- Raw material Certificates of Analysis (CoAs) — approved before use
- Packaging material CoAs
- Finished product analytical results against the registered specification
- Analytical raw data and instrument printouts (chromatograms, weights)
- Microbiological / sterility results where applicable
- Stability sample placement record (commitment / ongoing study)
- Closed OOS and OOT investigations, if any were raised
Packaging and labelling records
- Packaging Batch Record (executed)
- Label and artwork reconciliation — issued vs used vs destroyed
- Specimen labels for the batch
- Tamper-evidence / serialisation verification
Quality system records
- Deviation reports raised during the batch — all closed with impact assessment
- Change control records affecting the batch
- CAPA references and prior-CAPA effectiveness checks
- Environmental monitoring data for the manufacturing area
- Training records confirming operators were qualified for the steps performed
If any one of these is missing, incomplete, or inconsistent with the others, the batch cannot be released until it is resolved. The release review is, in effect, a completeness-and-consistency check across this entire list.
The five reviews behind the release
The documents above are reviewed in a defined sequence:
1. Batch Manufacturing Record (BMR) review
QA reviews the complete manufacturing record — were all steps followed per the master formula, all in-process checks completed, all critical parameters within limits, and the yield within range?
2. Batch testing review
QA verifies testing is complete and compliant — raw material CoAs approved, in-process and finished-product results within specification, stability samples placed, and any OOS/OOT investigations closed.
3. Packaging record review
Correct labels and artwork, full reconciliation of labels and packaging material, no mix-up incidents, tamper-evident features intact.
4. Deviation and CAPA review
All deviations during the batch documented and closed, impact assessed, CAPA initiated where required, and previous CAPA effectiveness verified.
5. Release decision
Based on all of the above, the authorised person records one of:
- Released — batch approved for sale/dispatch
- Rejected — batch fails quality criteria
- Quarantined — held pending investigation or additional testing
What regulators require
CDSCO, US FDA, EU and WHO-GMP all expect the same things from the release record:
- Complete traceability of the review process
- Documented evidence of QA review of each document above
- Signature and date of the releasing authority (the authorised/qualified person)
- Every deviation fully investigated and closed before release
- A complete audit trail of all changes
Paper-based release meets these requirements — but barely. It is slow, error-prone, and a nightmare to retrieve during an inspection, precisely because the dossier is spread across dozens of separate documents in different files and folders.
The digital batch release workflow
Running release as a controlled, stage-based workflow turns that document pack into a single connected record. The stages:
1. Production complete — production team submits the BMR for review
2. QA document review — QA reviews BMR, testing records, packaging records
3. Deviation check — QA verifies all deviations are closed
4. QC results review — QC confirms all testing complete and within spec
5. Authorised person review — final review by the releasing signatory
6. Released / rejected — batch status updated
At each stage, a release checklist captures the document review point, its status, and remarks — for example:
- BMR reviewed — Yes / No
- All in-process checks done — Yes / No
- Yield within range — Yes / No (e.g. actual 98.2%)
- Deviations closed — Yes / No (e.g. DEV-045 closed)
- CoAs verified — Yes / No
- Stability samples placed — Yes / No
With automatic controls built in:
- A batch can't be released if any deviation is open
- QC results must be approved before QA review proceeds
- The authorised person sees a summary of every previous review
- A complete audit trail records who reviewed what, and when
Why this matters for inspections
When an inspector asks, "Show me the release record for Batch B-2024-0347."
With paper: hunt through files, find the right folder, locate the BMR review sheet, the QC results, the deviation records, the label reconciliation. Thirty minutes, if nothing is misfiled.
With Flobri: search the batch number → see the complete release workflow — every review, every checklist item, every signature, every timestamp, with each linked document in one place. Thirty seconds.
How to set it up in Flobri
Describe the process in plain language:
"Production submits a completed batch for release. QA reviews the manufacturing record, testing results, and deviations using a checklist grid. QC confirms all tests passed. The authorised person gives final approval. The batch is released or rejected."
Flobri generates the workflow with checklist grids, approval routing, and audit trails — and links each batch to its deviations, OOS investigations, change controls and CAPAs, so the whole release dossier is one connected record.
Go to insights.flobri.com/build and describe your batch release process.
Frequently asked questions
What documents are required for batch release in pharma?
The core release pack is the executed BMR/BPR, in-process control records, yield reconciliation, line clearance, raw material and finished-product CoAs and analytical data, the packaging batch record with label reconciliation, closed deviation and OOS/OOT investigations, change control and CAPA references, environmental monitoring data, and equipment calibration and operator training records — all reviewed and signed by QA and the authorised person.
Who is authorised to release a batch?
A designated authorised person (in the EU, a Qualified Person) named in the site's quality system, with the training and authority to make the final release decision and sign the release record.
Can a batch be released with an open deviation?
No. Every deviation raised during the batch must be investigated and closed, with impact assessed, before the batch is released. A controlled workflow enforces this by blocking release while any linked deviation is open.
What's the difference between release, rejection and quarantine?
Released means the batch is approved for sale or dispatch; rejected means it fails quality criteria and cannot be sold; quarantined means it is held pending investigation or additional testing before a final decision.
Flobri digitises pharmaceutical batch release with structured document checklists, deviation tracking, multi-level review, and audit-ready records — compliant with GMP requirements, built around how your quality team already works.